State running out of drug to treat mucormycosis
Updated:
Updated:
Many families, hospitals finding it difficult to source them
Share Article
Many families, hospitals finding it difficult to source them The supply of the anti-fungal drugs Liposomal Amphotericin B or Amphotericin B, which are vital for treating mucormycosis, is drying up in Tamil Nadu with many patients’ families and hospitals finding it difficult to source them.
Mucormycosis, a serious fungal infection now predominantly affecting people post-COVID-19 with uncontrolled diabetes, has been on the rise in several parts of the country. With cases gradually increasing in Tamil Nadu as well, the demand for the drug has shot up.